Carcinoma, Non-Small-Cell Lung D002289

Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Neoplasms » Carcinoma, Bronchogenic » Carcinoma, Non-Small-Cell Lung

Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Tract Neoplasms » Lung Neoplasms » Bronchial Neoplasms » Carcinoma, Bronchogenic » Carcinoma, Non-Small-Cell Lung

Description

A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.   MeSH

Hierarchy View


Phase 3 Indicated Drugs (187)

Phase 2 Indicated Drugs (540)

1650-g vaccine

18f arabinosyl guanine

18f-flt-tep

18f fluoroglucose

2-fluoropropionyl-labeled pegylated dimeric rgd peptide

68ganota-anti-her2 vhh1

68ga-rm2

89zr-pembrolizumab

99mtc ecdg

ab-106

ab-16b5

abt-510

abt-751

abt-869

abtl0812

ac0010ma

acalabrutinib (calquence)

aciclovir (zovirax)

adenoviral vector expressing hsv-tk

adxs11-001

adxs-503

agen1884

aglatimagene besadenovec

ags-003

ak104

ak112

al2846

alacizumab pegol

alclometasone (aclovate)

aldesleukin (proleukin)

aldoxorubicin

alisertib

alkotinib

allogeneic cik cells

alpha (1,3) galactosyltransferase expressing allogeneic tumor cells

alrn-6924

amifostine (ethyol)

anastrozole (arimidex)

anetumab ravtansine

ang1005

angiostatin

antineoplaston a10

anti-ny eso-1 mtcr pbl

apg-115

apr-246

apricoxib

arag

armodafinil (nuvigil)

as15

asp0739

atl001

auranofin (ridaura)

autologous natural killer cells

autologous T cell memory cells

autologous tumor infiltrating lymphocytes

autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes

auy922

avitinib

azacitidine (vidaza)

azd-4547

azd-5672

azd6738

azd9150

BA3011

bay94-9392

bbt-176

belinostat (beleodaq)

berzosertib

betamarc

betamethasone (celestone)

bi 1361849

bi 1482694

bi-2536

bifidobacterium animalis

bifidobacterium longum

binimetinib (mektovi)

bintrafusp alfa

blu-701

blu-945

blueberry allergenic extract

bms-275183

bms-690514

bms-813160

bms-844203

bms-986207

bms-986340

bortezomib (velcade)

bp102

brentuximab vedotin (adcetris)

brivanib alaninate

bt-001

buparlisib

bupropion (wellbutrin)

cabazitaxel (jevtana kit)

cab-ror2-adc

calcitriol (rocaltrol)

can04

cb-839

cc-486

cd1c (bdca-1)+ / cd141 (bdca-3)+ mydc

cdx-1140

cdx-301

cediranib

cg8123

chadox1-magea3-nyeso

chidamide

ci-1040

cik cells

cilengitide

cixutumumab

ckd602

clarithromycin (biaxin)

clazakizumab

cln-081

cm082

cm-24

cobimetinib (cotellic)

compound 121564

conatumumab

copanlisib (aliqopa)

cpi-613

crenolanib

curcumin

cv301

cv9201

cx-2009

cx-2029

cyclobenzaprine (flexeril)

d-1553

dapsone (aczone)

darleukin

dasatinib (sprycel)

dc-cik cells

dcvac/luca

dec-205/ny-eso-1 fusion protein cdx-1401

decitabine (dacogen)

defactinib

dendritic cells

desloratadine (clarinex)

digoxin (lanoxin)

dihydroartemisinin

dinaciclib

dovitinib

doxorubicin (Doxil)

doxycycline (vibramycin)

dpx-survivac

dribbles

drozitumab

drp-104

dsp107

dupilumab (dupixent)

ec20

echinomycin

ef5

efatutazone

eftilagimod alpha

egf816

emb-01

emibetuzumab

encorafenib (braftovi)

ensartinib

entinostat

envafolimab

enzastaurin

ephb4-hsa fusion protein

epirubicin (ellence)

epothilone

eras-007

eras-601

erdafitinib (Balversa)

etalocib

etbx-011

etbx-051

etbx-061

etirinotecan pegol (Onzeald)

everolimus (zortress)

evofosfamide

exemestane (aromasin)

f16il2

ferumoxytol (feraheme)

ficlatuzumab

finasteride (Proscar)

fl-101

flotegatide

fludarabine (fludara)

fluoromisonidazole

fluorothymidine

fluorouracil (efudex)

fluzoparib

fostamatinib

fulvestrant (faslodex)

futuximab

gadolinium

galunisertib

gamma-glutamyl-s-(benzyl)-cysteinyl-r(-)-phenylglycine diethyl ester

ganitumab

ganoderma lucidum spore

gc1008

gc4711

gen1042

gen1044

genetically modified dc

genistein

gi-4000

gi-6301

gilteritinib

ginsenoside h dripping

glesatinib

glumetinib

gosspyl acetate

grapiprant

grn-1201

grt-c901

grt-c903

grt-r902

grt-r904

gsk 249553

gti-2040

guadecitabine

ha121-28

hh2710

hlx07

hlx208

hmbd-001

hocena

hs110 vaccine

human fecal microbiota

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil)

humax-axl-adc

humax-il8

hydroxychloroquine (plaquenil)

iab22m2c

ibi318

idelalisib (zydelig)

imatinib (gleevec)

imexon

imgatuzumab

imiquimod (aldara)

immune killer cells

immuvac

imprime pgg

incb086550

indocyanine green (ic-green)

indoximod

infliximab (remicade)

iniparib

interferon alpha-2b (Intron-A)

interleukin-10

io102

ionis-stat3rx

ipatasertib

ispinesib

it-101

itacitinib

itraconazole (sporanox)

ixabepilone (ixempra)

jab-21822

jab-3068

jab-8263

jmt101

jtx-2011

jtx-4014

keynatinib

koc1

kos-1584

l19il2

ladiratuzumab vedotin

lapatinib (tykerb)

lenalidomide (revlimid)

letrozole (femara)

leucovorin

lifileucel

linsitinib

litronesib

lmb-100

ln-145

lucanthone hydrochloride

lucitanib

lung cancer specific cytotoxic lymphocytes

lurbinectedin

l-vax

ly2181308

ly-3023414

ly3295668

mage-a1-specific t cell receptor-transduced autologous t-cells

malic acid

mapatumumab

matuzumab

mcla-128

MCLA-129

mdna11

melcancervac

merestinib

mesna (mesnex)

metformin (glucophage)

methotrexate

methylprednisolone (medrol)

metronidazole (flagyl)

mgc018

mgdc265

mifepristone (mifeprex)

milataxel

mils™ - nsclc

minocycline (minocin)

mirtazapine (remeron)

mistletoe extract

mk-0646

mk-4280

mk-4830

mk-5890

mocetinostat

monalizumab

mp0250

mrg002

mrg003

ms-20

msk-2206

muc-1 peptide vaccine

mva-magea3

myoinositol

n803

naptumomab estafenatox

navarixin

nbtxr3

nc318

nelfinavir (viracept)

neoantigen reactive t cells

neo-masct

nerlynx

ngm707

ngr-htnf

nimotuzumab

ningetinib

nir178

nitroglycerin (transderm-nitro)

nk-92

nk cell

nktr-214

novobiocin (albamycin)

nrx194204

nt-17

obinutuzumab (gazyva)

oc-001

ocz103-os

olaratumab (lartruvo)

oleclumab

olmutinib

ombrabulin

omo-103

onalespib

onc201

onc-392

or2805

ortataxel

oshadi d

oshadi r

palbociclib (ibrance)

palifermin (kepivance)

panitumumab (vectibix)

parsatuzumab

patupilone

pbf-509

pd-0325901

pdc*lung01

pelitinib

pemigatinib

penpulimab

pentoxifylline (trental)

perifosine

personalized neoantigen vaccine

pertuzumab (perjeta)

pevonedistat

pf-06459988

pf-07104091

pg545

phenylacetic acid (ucephan)

phenylacetylgluatmine

phytosome

pi-88

picropodophyllin

pictilisib

pimasertib

pioglitazone (actos)

pivanex

plb1001

poly-iclc

ponatinib (iclusig)

poziotinib

pr-104

pralatrexate (folotyn)

prame protein

pt-112

qbkpn

quaratusugene ozeplasmid

rabusertib

ranpirnase (Onconase)

rapa-201 autologous t cells

rapamycin

rbn-2397

rc48-adc

recombinant adenoviral human p53 gene

regn5093

regorafenib (stivarga)

relatlimab

reolysin

retifanlimab

rgd-k5

rhil-7-hyfc

ridaforolimus

risperidone (risperdal)

rmc-4630

ro4929097

ro5452802

ro5479599

ro7198457

rogaratinib

romidepsin (istodax)

romiplostim (nplate)

roniciclib

roscovitine

rosiglitazone

rp1

rq-00000007

rrx-001

rucaparib (rubraca)

ruxolitinib (jakafi)

s-1

s-3304

s-488410

s-588410

saf-189s

sagopilone

salirasib

sapacitabine

sapanisertib

sapitinib

saracatinib

sasanlimab

satraplatin

sbt6050

sc-43

sea-cd40

selumetinib

sepantronium bromide

seribantumab

sgn-15

shr6390

shr-a1811

sh t00268c

silibrin

simvastatin (zocor)

sirolimus (rapamune)

sitagliptin (januvia)

snk01

sonolisib

sovateltide

spartalizumab

st-067

sta-4783

suramin

surufatinib

sym015

t3011

tak-931

tamibarotene

tanespimycin

tarloxotinib

tas-114

tasidotin

tasisulam

tc-210 t cells

tc-99m albumin

tc-99m dtpa

telaglenastat

telaglenestat

temsirolimus (torisel)

tepotinib

teprotumumab

tergenpumatucel-l

tetrahydrouridine

tew-7197

thymalfasin (zadaxin)

tigatuzumab

tiotropium (spiriva)

tisotumab vedotin

titanium silicide

tj004309

tocilizumab (actemra)

tomivosertib

tozasertib

tpx-0046

tpx-0131

tq-b3101

trastuzumab (herceptin)

trastuzumab emtansine (kadcyla)

trebananib

tresulfan

triapine

trigriluzole

trilaciclib

triprizumab

tt-10

ttk

tucatinib

tumor-pulsed dendritic cells

ty-9591

ucpvax

uracil

urlc10

utidelone

vactosertib

valaciclovir (Valtrex)

vatalanib

vedolizumab (entyvio)

vegfr1

vegfr2

viagenpumatucel-l

vigil

vinflunine

vismodegib (erivedge)

vistusertib

vitamin c

vitespen

vls-101

volasertib

vosaroxin

vs-6766

VSV-IFNβ-NIS

vx-001

vx-970

vynfinit

wst11

xl999

xzp-5955

young tumor infiltrating lymphocytes

yq1

zalutumumab

zarnestra

zibotentan

zn-c3

Phase 1 Indicated Drugs (339)


Organization Involved with Phase 3 Indications (345)

AbbVie

Acea Bio

Actavis

Activate Immunotherapy

Agennix

Agouron

AIO-Studien-gGmbH

Akeso Pharmaceuticals, Inc.

Aktion Bronchialkarzinom e.V.

Allist Pharmaceuticals, Inc.

Alphamab Co., Ltd.

ArQule

Assign Clinical Research GmbH

Association NVALT Studies

Astellas

Australasian Lung Cancer Trials Group

Avid Bioservices

Badalona Hospital Germans Trias i Pujol

Bayer

BeiGene

Beijing Mabworks Biotech Co., Ltd.

Beta Pharma, Inc.

BeyondSpring Pharmaceuticals Inc.

Biocad

Biodesix Inc.

Bioikos Ambiente Srl

Biothera

Bioven

Blueprint Medicines Corporation

Boston Biomedical

Boston University

Bureau of Science and Technology of Guangxi Province, China

Canadian Cancer Trials Group

Cancer and Leukemia Group B (CALGB)

Cancer Research UK

Cantonal Hospital of St. Gallen

Capital Medical University

Case Western Reserve University

Cellectar, Inc

Central and Eastern European Oncology Group

Central European Society for Anticancer Drug Research (CESAR)

Central South University

Centre Hospitalier Intercommunal Creteil

Centro de Pesquisas Oncológicas - CEPON

Centus Biotherapeutics Limited

Changhai Hospital

CH Annecy

China Medical University

Chinese Society of Lung Cancer

Chinese Thoracic Oncology Group

Chinese University of Hong Kong

Chonnam National University

CHU Morvan

Chungbuk National University

CIMAB, Cuba

Cipla

Clovis Oncology

Columbia University

Cornell University

CStone Pharmaceuticals

CTI BioPharma

Daiichi Sankyo

Dalian Medical University

Dartmouth University

Department of Veteran Affairs

Duke University

Dutch Society of Physicians for Pulmonology and Tuberculosis

Eastern Cooperative Oncology Group

ECOG-ACRIN Cancer Research Group

Eisai

Emory University

Erasmus University Rotterdam

Eurofarma Laboratorios S.A.

European Lung Cancer Working Party

European Organisation for Research and Treatment of Cancer

European Thoracic Oncology Platform

Exelixis

Fatebenefratelli Hospital

Federation of Italian Cooperative Oncology Groups

First People's Hospital of Hangzhou

Fondazione Giovanni Pascale

Free University of Amsterdam

Fudan University

Fujian Medical University

Fundación GECP

Gansu Provincial Hospital

Genentech

Genta

Genzyme

GlaxoSmithKline

Gottfried Wilhelm Leibniz Universität Hannover

Government of Brazil

Government of Canada

Government of Japan

Government of Mexico

Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Groupe Francais De Pneumo-Cancerologie

Groupe Français de Pneumo-Cancérologie

Groupe Hospitalier Paris Saint Joseph

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Gruppo Oncologico del Nord-Ovest

Gruppo Oncologico Italia Meridionale

Gruppo Oncologico Italiano di Ricerca Clinica

GTx

Guangdong Academy of Medical Sciences

Guangdong Pharmaceutical University

Guangdong Province Clinical Trial Association

Guangxi Medical University

Guangzhou Medical University

Guizhou Medical University

Hamamatsu University

Hannover Clinical Trial Center GmbH

Harvard University

Hellenic Oncology Research Group

Helsinn

Hengrui Therapeutics, Inc.

Henry Ford Health System

Hoosier Cancer Research Network

Hospital Amaral Carvalho

Hospital Avicenne

Humanitas University

Hutchison MediPharma

Icahn School of Medicine at Mount Sinai

ICON

ILEX

Imclone

Immunotec Inc.

Incyte

Indiana University

Inje University

Innogene Kalbiotech Pte. Ltd

Innovent Biologics (Suzhou) Co. Ltd.

Institut Gustave Roussy

Insud Pharma

Intergroupe Francophone de Cancerologie Thoracique

Intertek

Ionis Pharmaceuticals, Inc.

IQVIA

Istituto Toscano Tumori

Janssen Pharmaceutica NV

Japan Agency for Medical Research and Development

Japan Clinical Oncology Group

Japan Multinational Trial Organization

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.

Jilin Provincial Tumor Hospital

Jilin University

Johns Hopkins University

Kadmon

Kael-GemVax Co., Ltd.

Kindai University

King Faisal Specialist Hospital

King Faisal University

Krankenhaus Bethanien gGmbH

Kyowa Hakko Kirin

LabCorp

Laboratorio Elea S.A.C.I.F. y A.

Laval University

Leiden University

Lifecenter Hospital

Ligand Pharmaceuticals

Linkoping University

Linyi Tumour Hospital

Loxo Oncology

Loyola University

LungenClinic Grosshansdorf

Maastricht University

Mario Negri Institute

Martha-Maria Krankenhaus Halle-Dölau gGmbH

Mayo Clinic

McMaster University

Medical Research Council

Medical University of Gdansk

Medical University of South Carolina

Medidata Solutions

MedImmune

Memorial Sloan-Kettering Cancer Center

Merck KGaA

Merck Serono

Mianyang Central Hospital

Millennium Pharmaceuticals

Mipharm SpA

Mirati Therapeutics Inc.

Nanjing Sanhome Pharmaceutical, Co., Ltd.

National Cancer Center, Japan

National Cancer Center, Korea

National Cancer Institute, France

National Cancer Institute (NCI)

National Center for Complementary and Integrative Health (NCCIH)

National Health and Medical Research Council, Australia

National Heart, Lung, and Blood Institute (NHLBI)

National Hospital Organization Osaka National Hospital

National Taiwan University

Netherlands Cancer Institute

Newcastle University

NewLink Genetics Inc

Niigata University Medical & Dental Hospital

NILAI CANCER INSTITUTE

North Central Cancer Treatment Group

Northwest Oncology Cooperative Group

Norwegian University of Science and Technology

Novelion Therapeutics

NovoCure Ltd.

NRG Oncology

OncoGenex Technologies

Ono Pharmaceuticals

Orion Corporation

Ortho Biotech, Inc.

OSE Immunotherapeutics

Pacific Biomarkers

Pacific Cancer Medical Center Inc.

Parexel

Pharmacia

Pharmacyclics

Philipps University of Marburg

Point Therapeutics

PPD

Prestige Brands

PTS International Inc.

Qilu Pharmaceutical Co., Ltd.

Qingdao Central Hospital

Qingdao University

Quercegen Pharmaceuticals

Radiation Therapy Oncology Group

Recombio SL

Regeneron

Royal Marsden Hospital NHS Trust

RTOG Foundation

Saladax Biomedical, Inc.

Samsung

San Giuseppe Moscati Hospital

SCRI Development Innovations

Seoul National University

SFJ Pharmaceuticals, Inc.

Shaanxi Provincial People's Hospital

Shanghai Chest Hospital, Shanghai, China

Shanghai Gebaide Biotechnology Co., Ltd.

Shanghai Henlius Biotech

Shanghai Junshi Bioscience Co.,Ltd.

Shanghai Municipal Science and Technology Commission

Shanghai University

Shanghai University of Traditional Chinese Medicine

Shanghai Yizhong Biotechnology Co., Ltd.

Shantou University

Sheffield Hallam University

Shijiazhuang Pharma Group (CSPC)

Sinocelltech Ltd.

SK Chemicals

Soochow University

Southern Medical University

Southwest Oncology Group

Spanish Lung Cancer Group

Spectrum Pharmaceuticals

Sponsor GmbH

Stanford University

State University of New York, Buffalo

State University of New York, Syracuse

Swedish Lung Cancer Study Group

Synta Pharmaceuticals Corp.

Sysmex Inostics GmbH

Takeda

Tel Aviv University

Telik

Temas srl

Temple University

The Christie NHS Foundation Trust

The Norwegian Lung Cancer Study Group

Thermo Fisher Scientific

The University of Texas, Dallas

Thomas Jefferson University

Tigermed Consulting Co., Ltd

Transgene

Tsinghua University

UNICANCER

Universidad Autonoma de Barcelona

Universidad Autonoma de Madrid

Universitair Ziekenhuis Gent

University Alicante

University of Aberdeen

University of Alabama

University of Alabama, Birmingham

University of Alberta

University of Antwerp

University of Bergen

University of Bern

University of Birmingham

University of Bologna

University of Bristol

University of Caen-Normandie

University of California, San Diego

University of Campania Luigi Vanvitelli

University of Chicago

University of Colorado, Denver

University of Copenhagen

University of Crete

University of Duisburg-Essen

University of Electronic Science and Technology of China

University of Genoa

University of Grenoble

University of Halle

University of Iowa

University of Kansas

University of Lausanne

University of Lille

University of Limoges

University of Liverpool

University of London

University of Lyon

University of Maryland

University of Melbourne

University of Milan

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Ottawa

University of Paris

University of Parma

University of Perugia

University of Pittsburgh

University of Rennes

University of Sheffield

University of South Florida

University of Strasbourg

University of Texas at Houston

University of Toronto

University of Ulsan

University of Washington

University of Western Australia

University of Western Brittany

University of Wisconsin

University of Zurich

Vanderbilt University

Vita-Salute University of Milano. Italy

Wake Forest University

Washington University in St. Louis

Wayne State University

West Japan Oncology Group

WuXi

Wuxi No. 4 People's Hospital

Xcovery

Xinjiang Medical University

Yonsei University

Yuhan Pharmaceutical Company

Zai Lab Pty. Ltd.

Zhejiang Betapharma Inc.

Zhejiang Teruisi Pharmaceutical Inc.

Organization Involved with Phase 2 Indications (587)

Aalborg University

Aarhus University

Abbott

Academic and Community Cancer Research United

Accord Research

Acerta Pharma

Acharya Tulsi Regional Cancer Treatment & Research Institute

Achilles Therapeutics Ltd

Adaptimmune

Adastra Pharmaceuticals

Advaxis, Inc.

Aegera Therapeutics

AESCA Pharma GmbH

AEterna Zentaris

Agenus Inc.

Ain Shams University

Aix-University of Marseille

Albert Einstein Israelite Hospital

Alethia Biotherapeutics

Allergan

Alliance Foundation Trials

Altor Bioscience

American Cancer Society, Inc.

American College of Radiology

American University of Beirut

Amphia Hospital Breda, the Netherlands

AmpliMed Corporation

Anaborex

AnewPharma

Angiochem Inc

AnHeart Therapeutics Inc.

Anhui Medical University

Anshan Tumor Hospital

Antisoma Research

A.O. Ospedale di Circolo di Busto Arsizio

A.O. Ospedale di Circolo di Melegnano

A.O. Santa Maria Degli Angeli - Pordenone

A.O. Valtellina e Valchiavenna

A.O. Villa Scassi

Apexigen, Inc.

Aptium Oncology

Arbeitsgemeinschaft medikamentoese Tumortherapie

Arcus Biosciences, Inc.

ARMO BioSciences

Arog Pharmaceuticals, Inc.

Array BioPharma

Arrys Therapeutics

Ascenta Therapeutics

ASL Brindisi

ASL TO4, Chivasso

Astex Pharmaceuticals, Inc.

Augusta University

AUSL della Romagna-RAVENNA

AUSL Piacenza - Ospedale Guglielmo da Saliceto

AUSL Viterbo - Ospedale di Belcolle

Austin Health

Autonomous University of Madrid

AVAX Technologies

Aventis

AVEO Pharmaceuticals

Axelar AB

Azienda Ospedaliera Ospedale Civile di Legnano

Azienda Ospedaliera San Camillo Forlanini

Azienda Ospedaliera San Gerardo di Monza

Azienda Ospedaliera San Giovanni Battista

Azienda Ospedaliera Santa Maria Degli Angeli

Azienda Ospedaliera Sant'Andrea, Roma

Azienda Ospedaliera S. Maria della Misericordia

Azienda Ospedaliera Spedali Riuniti di Livorno, Livorno

Azienda Provinciale per i Servizi Sanitari della Provincia Autonoma di Trento

Azienda Sanitaria dell'Alto Adige

Azienda Sanitaria Locale n.2 Savonese

Azienda USL 4 Prato

Bank of Cyprus Oncology Centre

Bankura Sammilani Medical College

Baptist Health

Bavarian Nordic

Baylor University

Beijing Pearl Biotechnology Limited Liability Company

Ben Gurion University

Benxi City hospital of Chinese medicine

BerGenBio ASA

Bicycle Therapeutics

Big Ten Cancer Research Consortium

BIND Therapeutics

BioAtla, LLC

Biomarck Pharmaceuticals

Biostar

Biotech Pharmaceutical Co., Ltd.

B.P. Poddar Hospital and Medical Research Ltd.

British Columbia Cancer Agency

Brown University

Burzynski Research Institute

Cadila Healthcare

Cairo University

Calithera Biosciences

Camargo Pharmaceutical Services

CanBas Co. Ltd.

CancerCare Manitoba

Cancer Council Queensland

Cancer Research and Biostatistics Clinical Trials Consortium

Cancer Research Institute

Cancer Research Network of Nebraska

Cancer Therapeutics Research Group

Cancer Treatment Centers of America

Candel Therapeutics

Cantonal Hospital Winterthur

Cardiff University

Casa di Cura Dott. Pederzoli - Peschiera del Garda

Cascadian Therapeutics Inc.

CASI Pharmaceuticals, Inc.

Cathay General Hospital

Catholic University of Korea

Cedars-Sinai Medical Center

Celldex Therapeutics

Cell Genesys

Cell>Point LLC

Center Eugene Marquis

Central European Cooperative Oncology Group

Centre Hospitalier de la Région d'Annecy

Changhua Christian Hospital

Chiltern International

Chimei Medical Center

China Three Gorges University, Yichang, China

Chinese Lung Cancer Surgical Group

Chipscreen Biosciences, Ltd.

Chittaranjan National Cancer Institute

CH Meaux

Choithram Hospital and Research Centre

Chong Kun Dang Pharmaceutical

Chongqing Precision Biotech Co., Ltd

Chroma Therapeutics

CHU Besançon

CHU de Grenoble

Chungnam National University

Chung Shan Medical University

City of Hope National Medical Center

City University of Hong Kong

Clearview Cancer Institute

Cliantha Research Limited

Clifford Hospital, Guangzhou, China

Clinical Research Technology S.r.l.

Clinica Universidad de Navarra

Commonwealth Cancer Center

Consorci Sanitari de Terrassa

Cooper Institute for Reproductive Hormonal Disorders

Corcept Therapeutics

Covance

Criterium, Inc.

CureVac AG

Cyclacel Pharmaceuticals, Inc.

CytRx

Daiichi

Dayton Oncology

Dazhou Central Hospital

Department of Defense

Dharmais Cancer Hospital

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Dracen Pharmaceuticals

DSM

East Carolina University

Effector Therapeutics

Endocyte

Ente Ospedaliero Cantonale

EpicentRx, Inc.

Epimmune

Ethisch Comité UZA

Far Eastern Memorial Hospital

Finnish Lung Cancer Group

First Hospital of Shijiazhuang City

First People's Hospital of Yulin

Fondation ARC

Fondazione Ricerca Traslazionale

Fortress Biotech

Fosun

Foundation Medicine

Free University of Brussels

French Lung Cancer Group

Frontier Science Foundation, Hellas

Fukushima Medical University

Fundación Althaia Manresa

G1 Therapeutics, Inc.

Gabrail Cancer Center

Gachon University

Galera Therapeutics

Gan and Lee Pharmaceuticals, USA

Gatot Subroto Central Army Hospital

Genmab

Genprex, Inc.

Georgetown University

Geron Corporation

Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH

Gilead Sciences

GKNM Hospital, Coimbatore, India

GlobeImmune

Golden Biotechnology Corp.

Government of Belgium

Government of Colombia

Government of France

Government of Singapore

Government of Taiwan

Gradalis, Inc.

Grupo de Investigación y Divulgación Oncológica

Grupo Gallego de Cancer de Pulmon

Grupo Portugues de Estudo do Cancro do Pulmao

Guangdong Province Association Study of Thoracic Oncology

Guangzhou University

Gujarat Cancer & Research Institute

GU Research Network, LLC

Gyeongsang University

Haemato-Onkologische Praxis und Tagesklinik

HagaZiekenhuis

Haining Health-Coming Biotech Co., Ltd.

Hanmi Pharmaceutical

Harbin Medical University

Heat Biologics

Hebei University

Hebrew University

Helix BioPharma Corporation

Hellenic Cooperative Oncology Group

Herbert Irving Comprehensive Cancer Center

HonorHealth Research Institute

Hospital Clinico Lozano Blesa

Hospital de Sagunto

Hospital General de Elda

Hospital General Universitario de Castellón

Hospital Pulau Pinang

Hospital Teresa Herrera

Hospital Universitario Arnau de Vilanova de Lleida

Hospital Virgen de los Lirios

Hubei Cancer Hospital

Hubei Clinical Research Collaboration Group

Humanetics Corporation

Human Genome Sciences

Humboldt University

H. Universitario Dr. Peset

HUYA Bioscience International

Huzhou University

Iaso General Hospital, Athens

Ignyta, Inc.

IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest

Illinois CancerCare, P.C.

Immunicum AB

Immunomedics

Immutep S.A.

Indira Ghandhi Institute of Medical Science

Infinity Pharmaceuticals, Inc.

Inivata

Institut de Cancérologie de la Loire (ICLN)

Institut de Cancerologie de l'Ouest Paul Papin

Institute of Oncology Dr. Rosell (IOR)

Institut für Klinische Krebsforschung IKF GmbH

Instituto Nacional de Enfermedades Respiratorias

Integrated Community Oncology Network

Invectys

InventisBio Inc.

Iovance

Ipsen

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Tumori Giovanni Paolo II, BARI

IUPUI

Ivy Life Sciences, Co., Ltd

James Graham Brown Cancer Center

Jeil Pharmaceutical Co., Ltd.

Jerome H. Check, M.D., Ph.D.

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Jiaxing Maternity and Child Health Care Hospital

Jinan University

Jingzhou Central Hospital

Johnson and Johnson

Jounce Therapeutics, Inc.

J. W. Goethe University

Kahr Medical

Kanagawa Prefectural Cancer Center

Kantonsspital Graubünden

Karyopharm Therapeutics Inc

Katholieke Universiteit Leuven

Kentuckiana Cancer Institute

Kentucky Lung Cancer Research Program

Kobe Minimally Invasive Cancer Center

Kobe University

Konkuk University

Korean South West Oncology Group

Korea University

Kosin University

Kunming Medical University

Kyoto University

Latin American Cooperative Oncology Group

Laura & Isaac Perlmutter Cancer Center

Leo W. Jenkins Cancer Center

Liaohe Oil Field General Hospital

Ligue contre le cancer, France

Louisiana State University

Lovelace Respiratory Research Institute

Ludwig Institute for Cancer Research

Lung Cancer Research Foundation

Lungen Clinic Grosshansdorf, Grosshansdorf, Germany

Lungenklinik Hemer

Lyon - URCOT

Malabar Institute of Medical Sciences

Maria Sklodowska Curie Children's Hospital

Mark Foundation

Mary Crowley Cancer Center

Mateon Therapeutics

McGill University

Medical College of Wisconsin

MedicalLogic

Medical University Innsbruck

Medical University of Vienna

Medigen Biotechnology Corporation

Medpace, Inc.

MedPacto, Inc.

MedSIR

Merrimack Pharmaceuticals

Mersana Therapeutics

Methodist Cancer Center, Houston, Texas

MFAR Clinical Research

MNJ Cancer Hospital Hyderabad

Molecular Partners AG

MolMed S.p.A.

Moorgreen Hospital, Southampton

Mt. Sinai Medical Center, Miami

Naestved Hospital

Nanchang University

Nanchong Central Hospital

NanOlogy, LLC

NantCell, Inc.

NantWorks

National Cheng Kung University

National Comprehensive Cancer Network

National Hospital Organisation Nagoya Medical Centre

National Institutes of Health (NIH)

National University of Singapore

National Yang-Ming University

Nektar Therapeutics

Nereus Pharmaceuticals, Inc.

Netaji Subhash Chandra Bose Cancer Research Institute

Nevada Cancer Institute

Newish Technology (Beijing) Co.,Ltd.

New Mexico Cancer Care Alliance

New York University

NextCure, Inc.

Ningbo No. 1 Hospital

Ningbo No. 2 Hospital

NKMAX Co., Ltd.

North Sichuan Medical University

Northwestern University

Novacea

Numoda

NuRx Pharmaceuticals, Inc.

Ohio State University

Olivia Newton-John Cancer Research Institute

Oncology Associates

Oncology Specialists, S.C.

Oncolytics Biotech

Onxeo

Optimum Therapeutics, LLC

Osaka University

Osakidetza

Oshadi Drug Administration

Ospedale di Circolo

Ospedale E. Profili

Ospedale Morelli, Sondalo

Ospedale Santa Croce-Carle Cuneo

Ospedale Santa Maria della Misericordia

Ospedale San Vincenzo Taormina

Ospedale S. Giovanni Bellinzona

Ospedale S.M. della Misericordia

Otsuka

Owensboro Medical Health System

OxOnc Development LP

Paloma Pharmaceuticals, Inc.

Panjin Central Hospital

parkview cancer institute

Patel Hospital Pvt. Ltd.

PDC*line Pharma SAS

Pennsylvania State University

Persahabatan General Hospital

Personal Genome Diagnostics (PGDx)

Peter MacCallum Cancer Centre

PharmaBio Development Inc.

PharmaJet, Inc.

PharmaMar

Pharmasciences

Pharmatech

Pharm-Olam International

Philogen S.p.A.

Phoenix Clinical Research Center

Plexxikon

Postgraduate Institute of Medical Education and Research

PrECOG, LLC.

Proacta, Incorporated

Progen Pharmaceuticals

Prologue Research International

Protgen Ltd

Providence Cancer Institute

Providence Health & Services

Puma Biotechnology, Inc.

Qu Biologics

Queen's University, Belfast

Rain Therapeutics Inc.

Regione Lombardia

Region Syddanmark

Reliable Cancer Therapies

RemeGen

Rhode Island Hospital

Rocky Mountain Cancer Centers

Rouen Normandy University

Rowan University

R-Pharm

R.S.T. Cancer Hospital & Research Centre

Rush University

Rutgers University

Samyang Biopharmaceuticals Corporation

Sanofi-Synthelabo

Schering-Plough

SciClone Pharmaceuticals

Seattle Genetics

Shanghai EpimAb Biotherapeutics Co., Ltd.

ShangHai HaiHe Pharmaceutical

Shengjing Hospital

Shenyang Chest Hospital

Shenzhen Hank Bioengineering Institute

Shenzhen Hornetcorn Bio-technology Company, LTD

Shenzhen SiBiono GeneTech Co.,Ltd

Shiga University

Shionogi

Showa University

Silvano Chiapparoli Logistica SpA

Singapore Clinical Research Institute

Soonchunhyang University

Southeastern Medical Oncology Center, Goldsboro

Southern Italy Cooperative Oncology Group

Southwestern Regional Medical Center

Stand Up To Cancer

Steba Biotech S.A.

St. John Providence Health System

St. Joseph Hospital Health Center

St. Luke's-Roosevelt Hospital Center

Stony Brook University

Sunesis Pharmaceuticals

Sunshine Lake Pharma Co., Ltd.

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Swedish Cancer Institute

Swedish Orphan Biovitrum

Swiss Group for Clinical Cancer Research

Symphogen A/S

Symphony Capital

Syndax Pharmaceuticals

Taichung Veterans General Hospital

Taipei Medical University

Taiwan Chest Disease Association

TAKO - Tiroler Arbeitskreis Onkologie

Tamir Biotechnology, Inc.

Tasly Pharmaceuticals, Inc.

TCR2 Therapeutics

Technical University of Munich

Technion University

Tennessee Oncology, PLLC

The Chest Hospital of Anhui Province

The First Affiliated Hospital of Dalian Medical University

The First People's Hospital of Hangzhou

The First People's Hospital of Jingzhou

The First People's Hospital of Lianyungang

The National Cancer Center

The People's Hospital of Liaoning Province

The Second People's Hospital of Sichuan

The University of Hong Kong

Threshold Pharmaceuticals

Titan Pharmaceuticals

Tohoku University

Translational Oncology Research International

Translational Research Informatics Center, Kobe, Hyogo, Japan

Trans Tasman Radiation Oncology Group

TTY Biopharm

Tuen Mun Hospital, Hong Kong

Tufts University

Tulane University

Tularik

Turning Point Therapeutics

Turnstone Biologics, Inc.

Tzu Chi General Hospital

UbiVac

Ultimovacs AS

Union Therapeutics

United BioSource Corporation

United States Army

Univerisiti Sains Malaysia

Universidad Complutense de Madrid

University of Adelaide

University of Amsterdam

University of Arizona

University of Auckland

University of Barcelona

University of Basel

University of Bordeaux

University of Cagliari

University of Calgary

University of California, Berkeley

University of California, Davis

University of California, Irvine

University of California, Los Angeles

University of California, San Francisco

University of Catania

University of Cologne

University of Colorado

University of Edinburgh

University of Florida

University of Franche-Comté

University of Freiburg

University of Geneva

University of Glasgow

University of Hamburg

University of Heidelberg

University of Illinois at Chicago

University of Ioannina

University of Kentucky

University of Leicester

University of Lorraine

University of Louisville

University of Malaya

University of Medicine and Dentistry of New Jersey

University of Miami

University of Michigan

University of Minnesota

University of Montreal

University of Munster

University of Nagasaki

University of Nebraska

University of New Mexico

University of New South Wales

University of Nottingham

University of Oslo

University of Palermo

University of Pavia

University of Pennsylvania

University of Rochester

University of Saskatchewan

University of Southern California

University of Southern Denmark

University of Sydney

University of Technology, Sydney

University of Tehran

University of Tennessee

University of Texas, San Antonio

University of Tokyo

University of Toledo

University of Toulouse

University of Turin

University of Utah

University of Valencia

University of Verona

University of Versailles

University of Vienna

University of Virginia

University of Western Ontario

Uppsala University

US Biotest

US Oncology

Vaccinex Inc.

ValiRx

Vaxon Biotech

Veeda Clinical Research

Velindre NHS Trust

Venn Life Sciences

Verastem, Inc.

Verlyx Pharma Inc

Victorian Cancer Council

Vion Pharmaceuticals

Vyriad, Inc.

Weleda AG

West Cancer Center

West Virginia University

WindMIL Therapeutics

WiSP GmbH

Wojewodzki Szpital

Worldwide Innovative Networking Association

Wuhan University

Wu Jieping Medical Foundation

Wyeth

Xijing Hospital

Yale University

Yeshiva University

Yiling Pharmaceutical Inc.

YM Biosciences

Zhengzhou University

Zivena

Organization Involved with Phase 1 Indications (132)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.